SKYEPHARMA TO PRESENT AT PIPER JAFFRAY
2008 HEALTH CARE CONFERENCE
LONDON, UK, 25 November 2008 -- SkyePharma PLC (LSE : SKP ) announces
today that the Company's Chief Executive Officer, Dr Ken
Cunningham, and Chief Financial Officer, Peter Grant, will participate
in the Piper Jaffray 2008 Health Care Conference in New York. Dr
Cunningham's "fireside chat" will take place at 2.30 pm EST (7.30
pm GMT) on Wednesday 3 December 2008. The webcast may be accessed at
http://www.skyepharma.com/investor-relations/presentations.html or
http://www.piperjaffray.com/conferences. An archived version of
the webcast will be available shortly thereafter. Please note that due
to the new format of this year's Piper Jaffray conference there will be
no slides available.
For further information please contact:
SkyePharma PLC Ken Cunningham +44 20 7491 1777
During office hours Peter Grant
Financial Dynamics (UK Enquiries) David Yates +44 20 7831 3113
Outside office hours Jonathan Birt
Trout Group (US Enquiries) Seth Lewis +1 617 583 1308
Brandon Lewis
About SkyePharma PLC
Using its proprietary drug delivery technologies, SkyePharma develops
new formulations of existing products to provide a clinical advantage
and life-cycle extension. The Company has twelve approved products in
the areas of oral, inhalation and topical delivery. The Group's
products are marketed throughout the world by leading
pharmaceutical companies. For more information, visit
www.skyepharma.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
Contact Information: Contacts: RNS Customer Services 0044-207797-4400 http://www.rns.com